CTLA4 and type 1 diabetes mellitus: Further confirmatory evidence for the critical role of CTLA4 in inhibiting downstream signaling from the TCR comes from studies in humans with a polymorphism in the CTLA4 gene region known as CT60 (A/G), which results in increased incidence of autoimmune diseases like type 1 diabetes, Graves disease and Addison’s disease [16].